Bulletin of Experimental Biology and Medicine 2012-08-01

Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses.

S V Stovbun, A V Kiselev, A M Zanin, T S Kalinina, T A Voronina, A I Mikhailov, A A Berlin

Index: Bull. Exp. Biol. Med. 153(4) , 455-8, (2012)

Full Text: HTML

Abstract

A concept of physicochemical forms of biologically active substances introduced in investigation of the action mechanism of ultra-low doses allows qualitative explanation of the main effects of ultra-low doses, chemical diversity of biologically active substances, and physical boundaries for these effects. Phenazepam was shown to possess activity in ultra-low doses only in disperse state, in the form of nanoparticles with a diameter <100-300 nm; these nanoparticles appear as micelles of surface active substances and solvated. Panavir possesses pharmacological activity in ultra-low doses and appears as nanoparticles with a diameter of 200-300 nm, which have uncompensated negative surface charge and polymer nature.

Related Compounds

  • Phenazepam
  • Probucol

Related Articles:

[Distribution of 14C-phenazepam and its metabolites in the liver, brain and blood plasma in single and prolonged administration to white rats].

1980-01-01

[Farmakol. Toksikol. 43(2) , 144-8, (1980)]

Phenazepam and its effects on driving.

2013-01-01

[J. Anal. Toxicol. 37(1) , 25-9, (2013)]

First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam.

2013-03-01

[Eur. J. Clin. Pharmacol. 69(3) , 361-3, (2013)]

Phenazepam: the drug that came in from the cold.

2012-04-01

[J. Forensic Leg. Med. 19(3) , 122-5, (2012)]

Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death.

2015-04-01

[Hum. Psychopharmacol. Clin. Exp. 27(3) , 254-61, (2012)]

More Articles...